Business
New German expert consensus provides first ri...
Smith+Nephew announced the publication of new German expert consensus guidance for single-use negative pressure wound therapy (sNPWT) in closed surgical incisions, recommending its use for at-risk patients and for wounds with an anticipated exudate volume of up to 300 ml per week. This guidance, supported by clinical evidence and practical recommendations, aims to reduce post-surgical complications like seroma and prolonged wound drainage, contributing to more predictable treatment outcomes. The PICO 7 system's features are highlighted as supporting this evidence-based practice, with the therapy clinically proven to activate the biology of healing and provide a bacterial barrier. Disclaimer*
About this update from Smith & Nephew Plc
New German expert consensus provides first risk-based recommendations for sNPWT use in closed surgical incisions Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces the publication of new consensus-based guidance - developed independently by expert clinicians for the use of single-use negative pressure wound therapy (sNPWT) in closed surgical incisions. The guidance is supported by practical clinical practice recommendations for Germany. Published in internationally recognised journal of surgery Die Chirurgie, the new German consensus was supported by Smith+Nephew, a pioneer in sNPWT and manufacturer of the PICO™7 sNPWT system. New consensus provides practical framework for post-surgical careThis new interdisciplinary consensus is the first in Germany to translate clinical evidence into practical real-world guidance.¹ It highlights the importance of structured preventative strategies in reducing the risk of post-surgical complications such as prolonged wound drainage and seroma formation that are known to adversely affect the healing process.¹ This is critical to helping avoid complications at an early stage, and contributes to more predictable treatment outcomes¹. sNPWT recommended for at-risk patientsBacked by strong clinical evidence, the consensus identifies sNPWT as a targeted preventive option for patients at increased risk of postoperative wound complications.¹ Risk factors include obesity, diabetes mellitus, smoking, and procedure-related factors such as prolonged surgical duration or revision surgery.¹ Having a clearly-defined patient criteria enables health professionals to tailor interventions based on individual risk profiles and supports clinical decision-making.¹ The new expert consensus also defines clear treatment boundaries, recommending sNPWT for wounds with an anticipated exudate volume of up to 300 ml per week.¹ As postoperative wound healing complications and surgical site infections (SSIs) remain a major challenge in surgical care, this provides clinicians with a much-needed practical framework for differentiated treatment decisions¹. PICO 7 device features support evidence-based practiceSmith+Nephew continues to contribute to pioneering the advance of wound care solutions, with ease of use exemplifying how PICO 7 therapy can be integrated into clinical pathways. Featuring a canister-free system ...
View stock analysis, news, and events for Smith & Nephew Plc